GeneDx Holdings Corp - Class A

NASDAQ: WGS

$27.20

-$0.05 (-0.2%)

Real Time Data Delayed 15 Min.

WGS Chart and Intraday Price

WGS Company Data

Asset Type	Stock
Exchange	NASDAQ
Currency	USD
Country	USA
Sector	REAL ESTATE & CONSTRUCTION
Industry	BLANK CHECKS
Address	C/O CORVEX MANAGEMENT LP, 667 MADISON AVENUE, NEW YORK, NY, US
Fiscal Year End	December
Latest Quarter	12/31/2023
Market Cap	221.98M USD
Shares Outstanding	26,053,600

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.